237 related articles for article (PubMed ID: 20304535)
1. Synthesis and antiproliferative activity of indolizine derivatives incorporating a cyclopropylcarbonyl group against Hep-G2 cancer cell line.
Shen YM; Lv PC; Chen W; Liu PG; Zhang MZ; Zhu HL
Eur J Med Chem; 2010 Jul; 45(7):3184-90. PubMed ID: 20304535
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and biological evaluation of chrysin long-chain derivatives as potential anticancer agents.
Lv PC; Wang KR; Li QS; Chen J; Sun J; Zhu HL
Bioorg Med Chem; 2010 Feb; 18(3):1117-23. PubMed ID: 20056425
[TBL] [Abstract][Full Text] [Related]
3. Cytotoxicity against cholangiocarcinoma cell lines of zerumbone derivatives.
Songsiang U; Pitchuanchom S; Boonyarat C; Hahnvajanawong C; Yenjai C
Eur J Med Chem; 2010 Sep; 45(9):3794-802. PubMed ID: 20541293
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis and biological evaluation of novel quinazoline derivatives as potential antitumor agents: molecular docking study.
El-Azab AS; Al-Omar MA; Abdel-Aziz AA; Abdel-Aziz NI; el-Sayed MA; Aleisa AM; Sayed-Ahmed MM; Abdel-Hamide SG
Eur J Med Chem; 2010 Sep; 45(9):4188-98. PubMed ID: 20599299
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and biological evaluation of thiazolidinone derivatives as potential EGFR and HER-2 kinase inhibitors.
Lv PC; Zhou CF; Chen J; Liu PG; Wang KR; Mao WJ; Li HQ; Yang Y; Xiong J; Zhu HL
Bioorg Med Chem; 2010 Jan; 18(1):314-9. PubMed ID: 19914835
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and biological evaluation of N-phenylsulfonylnicotinamide derivatives as novel antitumor inhibitors.
Zhang H; Lu X; Zhang LR; Liu JJ; Yang XH; Wang XM; Zhu HL
Bioorg Med Chem; 2012 Feb; 20(4):1411-6. PubMed ID: 22277588
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and structure-activity relationships of N-benzyl-N-(X-2-hydroxybenzyl)-N'-phenylureas and thioureas as antitumor agents.
Li HQ; Yan T; Yang Y; Shi L; Zhou CF; Zhu HL
Bioorg Med Chem; 2010 Jan; 18(1):305-13. PubMed ID: 19914837
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and in vitro antitumor activity of 4-aminoquinoline and 4-aminoquinazoline derivatives targeting EGFR tyrosine kinase.
Abouzid K; Shouman S
Bioorg Med Chem; 2008 Aug; 16(16):7543-51. PubMed ID: 18678492
[TBL] [Abstract][Full Text] [Related]
9. Design and synthesis of N-phenylacetyl (sulfonyl) 4,5-dihydropyrazole derivatives as potential antitumor agents.
Liu XH; Ruan BF; Liu JX; Song BA; Jing LH; Li J; Yang Y; Zhu HL; Qi XB
Bioorg Med Chem Lett; 2011 May; 21(10):2916-20. PubMed ID: 21486698
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, molecular modeling and biological evaluation of 2-(benzylthio)-5-aryloxadiazole derivatives as anti-tumor agents.
Liu K; Lu X; Zhang HJ; Sun J; Zhu HL
Eur J Med Chem; 2012 Jan; 47(1):473-8. PubMed ID: 22119130
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, biological evaluation and molecular docking studies of amide-coupled benzoic nitrogen mustard derivatives as potential antitumor agents.
Zheng QZ; Zhang F; Cheng K; Yang Y; Chen Y; Qian Y; Zhang HJ; Li HQ; Zhou CF; An SQ; Jiao QC; Zhu HL
Bioorg Med Chem; 2010 Jan; 18(2):880-6. PubMed ID: 20005116
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of novel 2,4'-bis substituted diphenylamines as anticancer agents and potential epidermal growth factor receptor tyrosine kinase inhibitors.
Abou-Seri SM
Eur J Med Chem; 2010 Sep; 45(9):4113-21. PubMed ID: 20580136
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, molecular docking and evaluation of thiazolyl-pyrazoline derivatives as EGFR TK inhibitors and potential anticancer agents.
Lv PC; Li DD; Li QS; Lu X; Xiao ZP; Zhu HL
Bioorg Med Chem Lett; 2011 Sep; 21(18):5374-7. PubMed ID: 21802290
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, inhibition of NO production and antiproliferative activities of some indole derivatives.
Sinicropi MS; Caruso A; Conforti F; Marrelli M; El Kashef H; Lancelot JC; Rault S; Statti GA; Menichini F
J Enzyme Inhib Med Chem; 2009 Oct; 24(5):1148-53. PubMed ID: 19555184
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and preliminary biological evaluation of novel taspine derivatives as anticancer agents.
Zhang J; Zhang Y; Shan Y; Li N; Ma W; He L
Eur J Med Chem; 2010 Jul; 45(7):2798-805. PubMed ID: 20304537
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological evaluation of 3',4',5'-trimethoxychalcone analogues as inhibitors of nitric oxide production and tumor cell proliferation.
Rao YK; Fang SH; Tzeng YM
Bioorg Med Chem; 2009 Dec; 17(23):7909-14. PubMed ID: 19875299
[TBL] [Abstract][Full Text] [Related]
17. Discovery of benzimidazole derivatives as novel multi-target EGFR, VEGFR-2 and PDGFR kinase inhibitors.
Li Y; Tan C; Gao C; Zhang C; Luan X; Chen X; Liu H; Chen Y; Jiang Y
Bioorg Med Chem; 2011 Aug; 19(15):4529-35. PubMed ID: 21724404
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and biological evaluation of pyrazolyl-thiazolinone derivatives as potential EGFR and HER-2 kinase inhibitors.
Qiu KM; Wang HH; Wang LM; Luo Y; Yang XH; Wang XM; Zhu HL
Bioorg Med Chem; 2012 Mar; 20(6):2010-8. PubMed ID: 22361272
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and in vitro cytotoxicity evaluation of novel naphthindolizinedione derivatives.
Defant A; Guella G; Mancini I
Arch Pharm (Weinheim); 2007 Mar; 340(3):147-53. PubMed ID: 17315260
[TBL] [Abstract][Full Text] [Related]
20. Design and synthesis of 4,6-substituted-(diaphenylamino)quinazolines as potent EGFR inhibitors with antitumor activity.
Li HQ; Li DD; Lu X; Xu YY; Zhu HL
Bioorg Med Chem; 2012 Jan; 20(1):317-23. PubMed ID: 22112541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]